MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/bmjresp-2025-003224

Медицинская библиотека · BMJ open respiratory research · 2025

Clinical and cost-effectiveness of diverse posthospitalisation pathways for COVID-19: a UK evaluation using the PHOSP-COVID cohort.

Briggs Andrew H, Ibbetson Andrew, Walters Archie, Houchen-Wolloff Linzy, Armstrong Natalie, Emerson Tristan, Gill Rhyan, Hastie Claire, Little Paul, Overton Charlotte, Pimm John, Poinasamy Krisnah, Singh Sally, Walker Samantha, Leavy Olivia C, Richardson Matthew, Elneima Omer, McAuley Hamish, Shikotra Aarti, Singapuri Amisha, Sereno Marco, Saunders Ruth M, Harris Victoria C, Greening Neil J, Harrison Ewen, Docherty Annemarie, Lone Nazir I, Quint Jennifer K, Chalmers James, Ho Ling-Pei, Horsley Alex Robert, Raman Betty, Wain Louise V, Brightling Christopher E, Marks Michael, Evans Rachael A, PHOSP-COVID Study Collaborative Group

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Long covid has emerged as a complex health condition for millions of people worldwide following the COVID-19 pandemic. Previously, we have categorised healthcare pathways for patients after discharge from hospital with COVID-19 across 45 UK sites. The aim of this work was to estimate the clinical and cost-effectiveness of these pathways.

METHODS

We examined prospectively collected data from 1013 patients at 12 months postdischarge on whether they felt fully recovered (self-report), number of newly diagnosed conditions (NDC), quality of life (EuroQoL-five dimension-five level (EQ-5D-5L) utility score compared with pre-COVID estimate) and healthcare resource costs (healthcare records). An analysis of the cost-effectiveness was performed by combining the healthcare resource cost and 1-year EQ-5D (giving a quality-adjusted life-year (QALY)) using statistical models that accounted for observed confounding.

RESULTS

At 1 year, 29% of participants felt fully recovered, and 41% of patients had an NDC. The most comprehensive services, where all patients could potentially access assessment, rehabilitation and mental health services, were more clinically effective when compared with either no service or light touch services (mean (SE) QALY 0.789 (0.012) vs 0.725 (0.026)), with an estimated cost per QALY of £1700 (95% uncertainty interval: dominated to £24 800).

CONCLUSION

Our analysis supports the need for proactive, stratified, comprehensive follow-up, particularly assessment and rehabilitation for adults after hospitalisation with COVID-19, showing these services are likely to be both clinically and cost-effective according to commonly accepted thresholds.

Для цитирования: Briggs Andrew H, Ibbetson Andrew, Walters Archie, Houchen-Wolloff Linzy, Armstrong Natalie, Emerson Tristan, Gill Rhyan, Hastie Claire, Little Paul, Overton Charlotte, Pimm John, Poinasamy Krisnah, Singh Sally, Walker Samantha, Leavy Olivia C, Richardson Matthew, Elneima Omer, McAuley Hamish, Shikotra Aarti, Singapuri Amisha, Sereno Marco, Saunders Ruth M, Harris Victoria C, Greening Neil J, Harrison Ewen, Docherty Annemarie, Lone Nazir I, Quint Jennifer K, Chalmers James, Ho Ling-Pei, Horsley Alex Robert, Raman Betty, Wain Louise V, Brightling Christopher E, Marks Michael, Evans Rachael A, PHOSP-COVID Study Collaborative Group. Clinical and cost-effectiveness of diverse posthospitalisation pathways for COVID-19: a UK evaluation using the PHOSP-COVID cohort.. BMJ open respiratory research. 2025. DOI: 10.1136/bmjresp-2025-003224.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.